MYC and hepatocellular carcinoma: Recently, most of the cancer-related mRNA targets of IGF2BP1 have been shown to promote tumor proliferation.[22] Huang et al[23] demonstrated that IGF2BP could bind to the m6A sites of the MYC gene and loss of IGF2BP inhibited the proliferation and migration of hepatocellular carcinoma and CC.